Provided by Tiger Trade Technology Pte. Ltd.

Artelo Biosciences, Inc.

0.6920
-0.0204-2.86%
Post-market: 0.6815-0.0105-1.52%19:09 EDT
Volume:108.90K
Turnover:76.98K
Market Cap:3.18M
PE:-0.06
High:0.7300
Open:0.7200
Low:0.6803
Close:0.7124
52wk High:28.98
52wk Low:0.6803
Shares:4.60M
Float Shares:4.35M
Volume Ratio:0.07
T/O Rate:2.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-11.3794
EPS(LYR):-37.5481
ROE:-705.71%
ROA:-127.92%
PB:0.64
PE(LYR):-0.02

Loading ...

Artelo Biosciences Inc - May Receive up to $50 Mln in Gross Proceeds From Sales to Square Gate - SEC Filing

THOMSON REUTERS
·
Mar 25

Artelo reports 6.38% mean weight gain in interim CAReS trial results for ART27.13

Reuters
·
Mar 24

Artelo Biosciences files to sell 1.64M shares of common stock

TIPRANKS
·
Mar 21

Artelo Biosciences Secures Bridge Financing Through Note Issuance

TIPRANKS
·
Mar 19

Artelo Biosciences issues USD 350,300 in 12% unregistered bridge notes in private placement

Reuters
·
Mar 19

BUZZ-U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies

Reuters
·
Mar 19

Top Midday Gainers

MT Newswires Live
·
Mar 19

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:39 AM

Reuters
·
Mar 18

BUZZ-U.S. STOCKS ON THE MOVE-Tencent, Air Products, Protagonist

Reuters
·
Mar 18

Vanderbilt Report: Artelo Biosciences Expands Into $16.3 Billion Glaucoma Market With Fully Funded Clinical Study

GlobeNewswire
·
Mar 18

BRIEF-Artelo Announces Third-Party Fully Funded Clinical Study Agreement To Evaluate Art27.13 In Glaucoma Patients

Reuters
·
Mar 18

Artelo Biosciences Shares Jump 30% Premarket After Co Plans UK Study of Glaucoma Drug

THOMSON REUTERS
·
Mar 18

BUZZ-Artelo Biosciences jumps as it plans UK study of glaucoma drug

Reuters
·
Mar 18

Artelo announces third-party fully funded clinical study agreement for ART27.13

TIPRANKS
·
Mar 18

Artelo Biosciences signs investigator-initiated clinical study to test ART27.13 in glaucoma patients

Reuters
·
Mar 18

Artelo Biosciences Inc - to Supply Art27.13 Capsules as Investigational Medicinal Product

THOMSON REUTERS
·
Mar 18

Artelo Biosciences Inc - First Patient Enrollment Anticipated in Q2 2026

THOMSON REUTERS
·
Mar 18

Artelo Announces Third-Party Fully Funded Clinical Study Agreement to Evaluate Art27.13 in Glaucoma Patients

THOMSON REUTERS
·
Mar 18

Artelo Biosciences Enacts Reverse Stock Split Amid Strain

TIPRANKS
·
Mar 18

NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 09:32 AM

Reuters
·
Mar 10